If you loved our Explainer on Cell and Gene Therapy, you'll love this new summarised version. This short report takes you through the key BIA member companies working in the AMR space, and explains the cutting-edge work taking place in the UK.
Explore Columbus Global's latest life science report featuring expert into the digital trends shaping the future of Pharma, MedTech and Biotech in 2026 and beyond
Poolbeg Pharma announces new research on two posters, by Poolbeg and The University of Manchester respectively, are being presented at the European Hematology Association Congress.
Poolbeg Pharma, a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces the first site activation for the first-in-patient POLB 001 TOPICAL* clinical trial has occurred.
Driven by world-class science and monumental funding, the UK TechBio sector is undergoing a profound paradigm shift – meet the innovative BIA members leading the charge
